Differential Expression of Inflammatory Cytokines and Stress Genes in Male and Female Mice in Response to a Lipopolysaccharide Challenge.
Sex plays a key role in an individual's immune response against pathogenic challenges such that females fare better when infected with certain pathogens. It is thought that sex hormones impact gene expression in immune cells and lead to sexually dimorphic responses to pathogens. We predicted that, in the presence of E. coli gram-negative lipopolysaccharide (LPS), there would be a sexually dimorphic response in proinflammatory cytokine production and acute phase stress gene expression and that these responses might vary among different mouse strains and times in a pattern opposite to that of body temperature associated with LPS-induced shock.



Interleukin-6 (IL-6), macrophage inflammatory protein-Iβ (MIP-1β), tumor necrosis factor alpha (TNF-α) and interleukin-1β (IL-1β) as well as beta-fibrinogen (Fgb) and metallothionein-1 (Mt-1) mRNA expression were measured at four time points (0, 2, 4 and 7 hours) after injection of E. coli LPS in mice from three inbred strains.



Statistical analysis using analyses of variance (ANOVAs) showed that the levels of the all six traits changed over time, generally peaking at 2 hours after LPS injection. Mt-1, Fgb, and IL-6 showed differences among strains, although these were time-specific. Sexual dimorphism was seen for Fgb and IL6, and was most pronounced at the latest time period (7 hours) where male levels exceeded those for females. Trends for all six cytokine/gene expression traits were negatively correlated with those for body temperatures.



The higher levels of expression of Fgb and IL6 in males compared with females are consistent with the greater vulnerability of males to infection and subsequent inflammation. Temperature appears to be a useful proxy for mortality in endotoxic shock, but sexual dimorphism in cytokine and stress gene expression levels may persist after an LPS challenge even if temperatures in the two sexes are similar and have begun to stabilize.
William and Mary, Department of Kinesiology, Williamsburg, VA, United States of America.
Ashleigh
A
Everhardt Queen
University of Oregon, Department of Biology, Eugene, OR, United States of America.
Megan
M
Moerdyk-Schauwecker
University of North Carolina at Charlotte, Department of Kinesiology, Charlotte, NC, United States of America.
Leslie M
LM
McKee
University of North Carolina at Charlotte, Department of Biology, Charlotte, NC, United States of America.
Larry J
LJ
Leamy
University of North Carolina at Charlotte, Department of Kinesiology, Charlotte, NC, United States of America.
Yvette M
0000-0002-8783-8679
YM
Huet
D000818:Animals; D054407:Chemokine CCL4 / Q000235:genetics; D016207:Cytokines / Q000235:genetics*; D005260:Female; D005340:Fibrinogen / Q000235:genetics; D015870:Gene Expression / Q000235:genetics*; D007249:Inflammation / Q000139:chemically induced* / Q000235:genetics*; D053583:Interleukin-1beta / Q000235:genetics; D015850:Interleukin-6 / Q000235:genetics; D008070:Lipopolysaccharides / Q000494:pharmacology*; D008297:Male; D008668:Metallothionein / Q000235:genetics; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D012333:RNA, Messenger / Q000235:genetics; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics
D054407:Chemokine CCL4; D016207:Cytokines; D053583:Interleukin-1beta; D015850:Interleukin-6; D008070:Lipopolysaccharides; D012333:RNA, Messenger; D014409:Tumor Necrosis Factor-alpha; D005340:Fibrinogen; D008668:Metallothionein